Published in Cancer Treat Rep on November 01, 1983
Secretion of Yop proteins by Yersiniae. Infect Immun (1990) 4.64
Role of p53 as a prognostic factor for survival in lung cancer: a systematic review of the literature with a meta-analysis. Eur Respir J (2001) 3.04
Clinical and molecular cytogenetic characterisation of a newly recognised microdeletion syndrome involving 2p15-16.1. J Med Genet (2006) 2.97
Chronic lymphocytic leukemic B cells but not normal B cells are rescued from apoptosis by contact with normal bone marrow stromal cells. Blood (1998) 2.66
The 21-residue surfactant peptide (LysLeu4)4Lys(KL4) is a transmembrane alpha-helix with a mixed nonpolar/polar surface. FEBS Lett (1996) 2.19
Secondary structure and dosage of soluble and membrane proteins by attenuated total reflection Fourier-transform infrared spectroscopy on hydrated films. Eur J Biochem (1990) 2.19
Significance of serum bactericidal activity in gram-negative bacillary bacteremia in patients with and without granulocytopenia. Am J Med (1984) 2.17
Attenuated total reflection infrared spectroscopy of proteins and lipids in biological membranes. Biochim Biophys Acta (1999) 2.17
Chemotherapy alone as initial treatment for primary CNS lymphoma in patients older than 60 years: a multicenter phase II study (26952) of the European Organization for Research and Treatment of Cancer Brain Tumor Group. J Clin Oncol (2003) 2.01
What studies of fusion peptides tell us about viral envelope glycoprotein-mediated membrane fusion (review). Mol Membr Biol (1998) 1.94
Determination of soluble and membrane protein structure by Fourier transform infrared spectroscopy. III. Secondary structures. Subcell Biochem (1994) 1.92
Survival improvement in resectable non-small cell lung cancer with (neo)adjuvant chemotherapy: results of a meta-analysis of the literature. Lung Cancer (2005) 1.92
The role of mitomycin in the treatment of non-small cell lung cancer: a systematic review with meta-analysis of the literature. Br J Cancer (2001) 1.82
Prognostic importance of serum soluble CD23 level in chronic lymphocytic leukemia. Blood (1996) 1.78
Detection of major bcr-abl gene expression at a very low level in blood cells of some healthy individuals. Blood (1995) 1.75
Yersinia enterocolitica type III secretion-translocation system: channel formation by secreted Yops. EMBO J (1999) 1.68
Expression of vascular endothelial growth factor (VEGF) and VEGF receptors in human neuroblastomas. Med Pediatr Oncol (2000) 1.66
Membrane molecule reorientation in an electric field recorded by attenuated total reflection Fourier-transform infrared spectroscopy. Biophys J (2001) 1.63
Determination of soluble and membrane protein structure by Fourier transform infrared spectroscopy. I. Assignments and model compounds. Subcell Biochem (1994) 1.63
Orthostatic tremor associated with cerebellar ataxia. J Neurol (1998) 1.57
The role of EGF-R expression on patient survival in lung cancer: a systematic review with meta-analysis. Eur Respir J (2002) 1.57
Membrane helix orientation from linear dichroism of infrared attenuated total reflection spectra. Biophys J (1999) 1.52
Saposin fold revealed by the NMR structure of NK-lysin. Nat Struct Biol (1997) 1.49
A reappraisal of the potential chemopreventive and chemotherapeutic properties of resveratrol. Carcinogenesis (2001) 1.49
Tolerance and effectiveness of recombinant interleukin-2 (r-met Hu IL-2 [ala-125]) and lymphokine-activated killer cells in patients with metastatic solid tumors. Eur J Cancer Clin Oncol (1989) 1.48
The convertases furin and PC1 can both cleave the human immunodeficiency virus (HIV)-1 envelope glycoprotein gp160 into gp120 (HIV-1 SU) and gp41 (HIV-I TM). J Biol Chem (1994) 1.46
The molecular composition of some lipid bilayer membranes in aqueous solution. J Membr Biol (1972) 1.44
Prophylactic cranial irradiation in small cell lung cancer: a systematic review of the literature with meta-analysis. BMC Cancer (2001) 1.44
Role of the carboxy terminus of Escherichia coli FtsA in self-interaction and cell division. J Bacteriol (2000) 1.43
Structure and topology of the influenza virus fusion peptide in lipid bilayers. J Biol Chem (1995) 1.41
Role of granulocyte and granulocyte-macrophage colony-stimulating factors in the treatment of small-cell lung cancer: a systematic review of the literature with methodological assessment and meta-analysis. Lung Cancer (2002) 1.40
Identification of the paired basic convertases implicated in HIV gp160 processing based on in vitro assays and expression in CD4(+) cell lines. J Biol Chem (1996) 1.40
Treatment of acute myelogenous leukemia. An EBMT-EORTC retrospective analysis of chemotherapy versus allogeneic or autologous bone marrow transplantation. Eur J Cancer Clin Oncol (1989) 1.40
Response to chemotherapy has predictive value for further survival of patients with advanced non-small cell lung cancer: 10 years experience of the European Lung Cancer Working Party. Eur J Cancer (1997) 1.40
Pilot study of amphotericin B entrapped in sonicated liposomes in cancer patients with fungal infections. Eur J Cancer Clin Oncol (1988) 1.38
The plicamycin and hydroxyurea combination chemotherapy for chronic granulocytic leukemia in myeloid transformation. Haematologica (1991) 1.38
Mitomycin, ifosfamide, cisplatin for non-small cell lung cancer: an implementation study. Monaldi Arch Chest Dis (2005) 1.38
Structural characterization of the hydrophobin SC3, as a monomer and after self-assembly at hydrophobic/hydrophilic interfaces. Biophys J (1998) 1.35
Evolution of microRNA expression during human bronchial squamous carcinogenesis. Eur Respir J (2008) 1.35
Lipid membrane fusion induced by the human immunodeficiency virus type 1 gp41 N-terminal extremity is determined by its orientation in the lipid bilayer. J Virol (1996) 1.32
Temporal patterns in the acoustic signals of beaked whales at Cross Seamount. Biol Lett (2008) 1.30
Causes of death in febrile granulocytopenic cancer patients receiving empiric antibiotic therapy. Eur J Cancer Clin Oncol (1984) 1.28
Secondary structure and orientation of the surfactant protein SP-B in a lipid environment. A Fourier transform infrared spectroscopy study. Biochemistry (1992) 1.28
A systematic review of the role of etoposide and cisplatin in the chemotherapy of small cell lung cancer with methodology assessment and meta-analysis. Lung Cancer (2000) 1.27
Determination of soluble and membrane protein structure by Fourier transform infrared spectroscopy. II. Experimental aspects, side chain structure, and H/D exchange. Subcell Biochem (1994) 1.24
Structure and orientation of the surfactant-associated protein C in a lipid bilayer. Eur J Biochem (1992) 1.24
Experimental antitumor activity against murine tumor model systems of 8-carbamoyl-3-(2-chloroethyl)imidazo[5,1-d]-1,2,3,5-tetrazin-4(3 H)-one (mitozolomide), a novel broad-spectrum agent. Cancer Res (1985) 1.22
Carbonic anhydrase IX antigen differentiates between preneoplastic malignant lesions in non-small cell lung carcinoma. Eur Respir J (1999) 1.20
Lactic acidosis: a metabolic complication of extensive metastatic cancer. Eur J Cancer Clin Oncol (1983) 1.18
EFNS Guidelines on diagnosis and treatment of brain metastases: report of an EFNS Task Force. Eur J Neurol (2006) 1.17
The acid activation of Helicobacter pylori toxin VacA: structural and membrane binding studies. Biochem Biophys Res Commun (1998) 1.16
Phase I study of docetaxel administered as a 1-hour intravenous infusion on a weekly basis. J Clin Oncol (1994) 1.16
Fusogenic segments of bovine leukemia virus and simian immunodeficiency virus are interchangeable and mediate fusion by means of oblique insertion in the lipid bilayer of their target cells. Proc Natl Acad Sci U S A (1992) 1.16
High-performance liquid chromatographic determination of amphotericin B in human serum. J Chromatogr (1987) 1.15
The low density lipoprotein receptor active conformation of apolipoprotein E. Helix organization in n-terminal domain-phospholipid disc particles. J Biol Chem (1998) 1.14
Orientation and structure of the NH2-terminal HIV-1 gp41 peptide in fused and aggregated liposomes. Biochim Biophys Acta (1993) 1.14
Activity of chemotherapy and immunotherapy on malignant mesothelioma: a systematic review of the literature with meta-analysis. Lung Cancer (2002) 1.13
Structure of the adriamycin-cardiolipin complex. Role in mitochondrial toxicity. Biophys Chem (1990) 1.13
Interaction of the lantibiotic nisin with membranes revealed by fluorescence quenching of an introduced tryptophan. Eur J Biochem (1996) 1.12
Orientation into the lipid bilayer of an asymmetric amphipathic helical peptide located at the N-terminus of viral fusion proteins. Biochim Biophys Acta (1990) 1.12
Apolipoprotein A-1 interacts with the N-terminal fusogenic domains of SIV (simian immunodeficiency virus) GP32 and HIV (human immunodeficiency virus) GP41: implications in viral entry. Biochem Biophys Res Commun (1992) 1.11
Secondary structure of diphtheria toxin and its fragments interacting with acidic liposomes studied by polarized infrared spectroscopy. J Biol Chem (1989) 1.10
Mode of insertion into a lipid membrane of the N-terminal HIV gp41 peptide segment. AIDS Res Hum Retroviruses (1988) 1.10
The different molar absorptivities of the secondary structure types in the amide I region: an attenuated total reflection infrared study on globular proteins. Anal Biochem (1996) 1.10
Neuromuscular changes with alloxan hyperglycemia. Electrophysiological, biochemical, and histological study in rats. Arch Neurol (1968) 1.10
The role of endosome destabilizing activity in the gene transfer process mediated by cationic lipids. FEBS Lett (1997) 1.09
Evidence of a specific complex between adriamycin and negatively-charged phospholipids. Biochim Biophys Acta (1980) 1.09
Theoretical and functional analysis of the SIV fusion peptide. EMBO J (1991) 1.09
Primary structure of diphtheria toxin fragment B: structural similarities with lipid-binding domains. J Cell Biol (1980) 1.09
Value of anion-gap determination in multiple myeloma. N Engl J Med (1977) 1.09
Novel antitumor artemisinin derivatives targeting G1 phase of the cell cycle. Bioorg Med Chem Lett (2001) 1.08
Screening for psychiatric disorders in a lymphoma out-patient population. Eur J Cancer (1992) 1.08
Attenuated total reflection IR spectroscopy as a tool to investigate the structure, orientation and tertiary structure changes in peptides and membrane proteins. Biopolymers (2000) 1.08
Interactions of aminoglycoside antibiotics with negatively charged lipid layers. Biochemical and conformational studies. Biochem Pharmacol (1984) 1.07
The interaction of miconazole and ketoconazole with lipids. Biochem Pharmacol (1982) 1.06
Localization in diphtheria toxin fragment B of a region that induces pore formation in planar lipid bilayers at low pH. FEBS Lett (1983) 1.05
[VEGF and survival of patients with lung cancer: a systematic literature review and meta-analysis]. Rev Mal Respir (2002) 1.05
Severe pericardial effusion in patients with concurrent malignancy: a retrospective analysis of prognostic factors influencing survival. Ann Surg Oncol (2008) 1.05
Purification of IpaC, a protein involved in entry of Shigella flexneri into epithelial cells and characterization of its interaction with lipid membranes. FEBS Lett (1997) 1.05
Dose/response study of aminohydroxypropylidene bisphosphonate in tumor-associated hypercalcemia. Am J Med (1987) 1.04
Tissue distribution and bioactivity of amphotericin B administered in liposomes to cancer patients. J Antimicrob Chemother (1991) 1.04
Tertiary stability of native and methionine-80 modified cytochrome c detected by proton-deuterium exchange using on-line Fourier transform infrared spectroscopy. Biochemistry (1995) 1.04
Structure-activity relationships of the B fragment of diphtheria toxin: the lipid-binding domains. Toxicon (1982) 1.04
Small-cell carcinoma of the lung: derivation of a prognostic staging system. J Clin Oncol (1991) 1.03
Human immunodeficiency virus type-1-specific immune responses induced by DNA vaccination are greatly enhanced by mannan-coated diC14-amidine. Eur J Immunol (1997) 1.02
A randomized study comparing a high and a standard dose of cisplatin in combination with etoposide in the treatment of advanced non-small-cell lung carcinoma. J Clin Oncol (1986) 1.02
A randomized study comparing cisplatin or carboplatin with etoposide in patients with advanced non-small-cell lung cancer: European Organization for Research and Treatment of Cancer Protocol 07861. J Clin Oncol (1990) 1.01
Deoxyribonucleic acid synthesis time of erythropoietic and granulopoietic cells in human beings. Nature (1966) 1.01
Characterization of the sequence of interactions of the fusion domain of the simian immunodeficiency virus with membranes. Role of the membrane dipole potential. J Biol Chem (1999) 1.01